Invention Grant
- Patent Title: Isotopically enriched arylsulfonamide CCR3 antagonists
-
Application No.: US14798356Application Date: 2015-07-13
-
Publication No.: US09637460B2Publication Date: 2017-05-02
- Inventor: Tai Wei Ly , Garrett Thomas Potter
- Applicant: Axikin Pharmaceuticals, Inc.
- Applicant Address: US CA San Diego
- Assignee: Axikin Pharmaceuticals, Inc.
- Current Assignee: Axikin Pharmaceuticals, Inc.
- Current Assignee Address: US CA San Diego
- Agency: Jones Day
- Main IPC: C07D241/08
- IPC: C07D241/08 ; A61K45/06 ; A61K31/495 ; C07B59/00
Abstract:
Provided herein are isotopically enriched arylsulfonamides, for example, of Formula I, that are useful for modulating CCR3 activity, and pharmaceutical compositions thereof. Also provided herein are methods of their use for treating, preventing, or ameliorating one or more symptoms of a CCR3-mediated disease, disorder, or condition.
Public/Granted literature
- US20150315158A1 ISOTOPICALLY ENRICHED ARYLSULFONAMIDE CCR3 ANTAGONISTS Public/Granted day:2015-11-05
Information query
